for Arterial Research
Thank you for your interest in our Arterial Research Initiative, a search to identify breakthrough research in arterial stiffness and vascular health, to further our commitment to driving the field of arterial health forward and improving patient outcomes.
Cardiex's SphygmoCor® technology is the global gold standard in measuring clinically relevant vascular biomarkers for arterial health with 300+ research studies, 47 clinical trials, and over 4,000 global installations to date. Cardiex's SphygmoCor XCEL and CONNEQT Pulse devices will enable you to obtain actionable vascular insights from your research initiative.
The Submission, Evaluation, and Voting Phases are now complete. We will be announcing the winners on Saturday, June 15 on the finalist page.
What are the next steps?
The Cardiex Arterial Research Initiative will have five phases:
- Submission Phase – Research submissions were accepted until 11:59pm March 31, 2024.
- Evaluation Phase - Following an administrative triage, proposals will be reviewed by a panel of Cardiex experts and evaluated against the Evaluation Criteria.
- Voting Phase – The Cardiex experts will select 10 finalists and present their ideas for peer voting.
- Selection Phase – The final winners of the Cardiex Arterial Research Initiative Award will be chosen by their peers through voting.
Prizes
The Cardiex Arterial Research Initiative prize, worth a total of USD$100,000.00, will be awarded to three winners and consists of Cardiex devices and data support. The prizes will be distributed as follows:
1 Grand Prize winner will receive (2) SphygmoCor XCEL, (20) CONNEQT Pulse, and $15,000 in Data Services.
2 Runner-Up winners will each receive (10) CONNEQT Pulse and $8,500 in Data Services.
Timing
The Submission Phase closed on March 31, 2024. The Evaluation and Voting phases run from April 2024 through June 2024. Winners will be announced in June 2024.
Contest Frequently Asked Questions
*Contest closes March 31, 2024, at 11:59 PM Eastern Time.